The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity along with a ...

The World Health Organization issued new guidelines recommending the use of GLP-1 drugs for adults with obesity and called for action on manufacturing and affordability.

The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally ...

WHO officially recognizes cannabis hyperemesis syndrome, a dangerous vomiting disorder linked to chronic marijuana use, ...

According to the WHO, more than one billion people around the world are affected by obesity. By 2030, it says that figure ...

On World AIDS Day, the World Health Organization (WHO) calls on governments and partners to rapidly expand access to new ...

The new World Health Organization guideline recognizes obesity as a chronic disease that can be treated with drug therapy as ...

The World Health Organization (WHO) has finally made its recommendations on using glucagon-like peptide-1 (GLP-1) ...

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said ...